Gene amplification听refers to a number of natural and artificial processes by which the number of copies of a听gene听is increased "without a proportional increase in other genes".
Market Analysis and Insights: Global Gene Amplification Technologies Market
The global Gene Amplification Technologies market is projected to grow from US$ 26680 million in 2024 to US$ 30040 million by 2030, at a Compound Annual Growth Rate (CAGR) of 2.0% during the forecast period.
The Gene Amplification Technologies Market is driven by the ever-increasing demand for sophisticated and precise tools in molecular biology, genetic research, and diagnostics. Gene amplification technologies, which include polymerase chain reaction (PCR) and other molecular techniques, play a pivotal role in replicating and analyzing DNA and RNA sequences. These technologies are essential for a wide range of applications, including disease diagnosis, genetic profiling, and drug development. As research and diagnostic capabilities advance, the demand for more sensitive, rapid, and cost-effective gene amplification methods continues to grow. However, a key challenge for this market is the need to keep pace with rapidly evolving research and diagnostic requirements, as well as the increasing demand for point-of-care and resource-limited settings. Overcoming issues related to sensitivity, specificity, and scalability while adhering to regulatory and quality control standards remains an ongoing challenge. Additionally, the market faces competition from alternative genetic analysis techniques and the need for continuous innovation to address emerging genetic challenges. Striking a balance between accuracy, affordability, and adaptability to diverse applications is essential for the continued growth of the Gene Amplification Technologies Market.
Report Covers:
This report presents an overview of global market for Gene Amplification Technologies market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Gene Amplification Technologies, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Gene Amplification Technologies, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Gene Amplification Technologies revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Gene Amplification Technologies market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Gene Amplification Technologies revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Abbott Laboratories
QIAGEN
Agilent Technologies
Bayer Corporation
Rubicon Genomics
BD
Roche Diagnostics
BioMerieux
Bio-Rad Laboratories
Cepheid
Life Technologies
Takara Bio
New England Biolabs
Illumina
Yikang Gene
Merck KGaA
Promega Corporation
Segment by Type
Polymerase Chain Reaction (PCR)
Loop Mediated Isothermal Amplification (LAMP)
Other
Segment by Application
Medical
Forensics
Paternity
Personnel Identification
Food safety
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Gene Amplification Technologies in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gene Amplification Technologies companies鈥� competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Gene Amplification Technologies revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene Amplification Technologies Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Polymerase Chain Reaction (PCR)
1.2.3 Loop Mediated Isothermal Amplification (LAMP)
1.2.4 Other
1.3 Market by Application
1.3.1 Global Gene Amplification Technologies Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Medical
1.3.3 Forensics
1.3.4 Paternity
1.3.5 Personnel Identification
1.3.6 Food safety
1.3.7 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gene Amplification Technologies Market Perspective (2019-2030)
2.2 Global Gene Amplification Technologies Growth Trends by Region
2.2.1 Gene Amplification Technologies Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Gene Amplification Technologies Historic Market Size by Region (2019-2024)
2.2.3 Gene Amplification Technologies Forecasted Market Size by Region (2025-2030)
2.3 Gene Amplification Technologies Market Dynamics
2.3.1 Gene Amplification Technologies Industry Trends
2.3.2 Gene Amplification Technologies Market Drivers
2.3.3 Gene Amplification Technologies Market Challenges
2.3.4 Gene Amplification Technologies Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Gene Amplification Technologies by Players
3.1.1 Global Gene Amplification Technologies Revenue by Players (2019-2024)
3.1.2 Global Gene Amplification Technologies Revenue Market Share by Players (2019-2024)
3.2 Global Gene Amplification Technologies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Gene Amplification Technologies, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Gene Amplification Technologies Market Concentration Ratio
3.4.1 Global Gene Amplification Technologies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene Amplification Technologies Revenue in 2023
3.5 Global Key Players of Gene Amplification Technologies Head office and Area Served
3.6 Global Key Players of Gene Amplification Technologies, Product and Application
3.7 Global Key Players of Gene Amplification Technologies, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Gene Amplification Technologies Breakdown Data by Type
4.1 Global Gene Amplification Technologies Historic Market Size by Type (2019-2024)
4.2 Global Gene Amplification Technologies Forecasted Market Size by Type (2025-2030)
5 Gene Amplification Technologies Breakdown Data by Application
5.1 Global Gene Amplification Technologies Historic Market Size by Application (2019-2024)
5.2 Global Gene Amplification Technologies Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Gene Amplification Technologies Market Size (2019-2030)
6.2 North America Gene Amplification Technologies Market Size by Type
6.2.1 North America Gene Amplification Technologies Market Size by Type (2019-2024)
6.2.2 North America Gene Amplification Technologies Market Size by Type (2025-2030)
6.2.3 North America Gene Amplification Technologies Market Share by Type (2019-2030)
6.3 North America Gene Amplification Technologies Market Size by Application
6.3.1 North America Gene Amplification Technologies Market Size by Application (2019-2024)
6.3.2 North America Gene Amplification Technologies Market Size by Application (2025-2030)
6.3.3 North America Gene Amplification Technologies Market Share by Application (2019-2030)
6.4 North America Gene Amplification Technologies Market Size by Country
6.4.1 North America Gene Amplification Technologies Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Gene Amplification Technologies Market Size by Country (2019-2024)
6.4.3 North America Gene Amplification Technologies Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Gene Amplification Technologies Market Size (2019-2030)
7.2 Europe Gene Amplification Technologies Market Size by Type
7.2.1 Europe Gene Amplification Technologies Market Size by Type (2019-2024)
7.2.2 Europe Gene Amplification Technologies Market Size by Type (2025-2030)
7.2.3 Europe Gene Amplification Technologies Market Share by Type (2019-2030)
7.3 Europe Gene Amplification Technologies Market Size by Application
7.3.1 Europe Gene Amplification Technologies Market Size by Application (2019-2024)
7.3.2 Europe Gene Amplification Technologies Market Size by Application (2025-2030)
7.3.3 Europe Gene Amplification Technologies Market Share by Application (2019-2030)
7.4 Europe Gene Amplification Technologies Market Size by Country
7.4.1 Europe Gene Amplification Technologies Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Gene Amplification Technologies Market Size by Country (2019-2024)
7.4.3 Europe Gene Amplification Technologies Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Gene Amplification Technologies Market Size (2019-2030)
8.2 China Gene Amplification Technologies Market Size by Type
8.2.1 China Gene Amplification Technologies Market Size by Type (2019-2024)
8.2.2 China Gene Amplification Technologies Market Size by Type (2025-2030)
8.2.3 China Gene Amplification Technologies Market Share by Type (2019-2030)
8.3 China Gene Amplification Technologies Market Size by Application
8.3.1 China Gene Amplification Technologies Market Size by Application (2019-2024)
8.3.2 China Gene Amplification Technologies Market Size by Application (2025-2030)
8.3.3 China Gene Amplification Technologies Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Gene Amplification Technologies Market Size (2019-2030)
9.2 Asia Gene Amplification Technologies Market Size by Type
9.2.1 Asia Gene Amplification Technologies Market Size by Type (2019-2024)
9.2.2 Asia Gene Amplification Technologies Market Size by Type (2025-2030)
9.2.3 Asia Gene Amplification Technologies Market Share by Type (2019-2030)
9.3 Asia Gene Amplification Technologies Market Size by Application
9.3.1 Asia Gene Amplification Technologies Market Size by Application (2019-2024)
9.3.2 Asia Gene Amplification Technologies Market Size by Application (2025-2030)
9.3.3 Asia Gene Amplification Technologies Market Share by Application (2019-2030)
9.4 Asia Gene Amplification Technologies Market Size by Region
9.4.1 Asia Gene Amplification Technologies Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Gene Amplification Technologies Market Size by Region (2019-2024)
9.4.3 Asia Gene Amplification Technologies Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Gene Amplification Technologies Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Gene Amplification Technologies Market Size by Type
10.2.1 Middle East, Africa, and Latin America Gene Amplification Technologies Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Gene Amplification Technologies Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Gene Amplification Technologies Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Gene Amplification Technologies Market Size by Application
10.3.1 Middle East, Africa, and Latin America Gene Amplification Technologies Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Gene Amplification Technologies Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Gene Amplification Technologies Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Gene Amplification Technologies Market Size by Country
10.4.1 Middle East, Africa, and Latin America Gene Amplification Technologies Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Gene Amplification Technologies Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Gene Amplification Technologies Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Gene Amplification Technologies Introduction
11.1.4 Abbott Laboratories Revenue in Gene Amplification Technologies Business (2019-2024)
11.1.5 Abbott Laboratories Recent Developments
11.2 QIAGEN
11.2.1 QIAGEN Company Details
11.2.2 QIAGEN Business Overview
11.2.3 QIAGEN Gene Amplification Technologies Introduction
11.2.4 QIAGEN Revenue in Gene Amplification Technologies Business (2019-2024)
11.2.5 QIAGEN Recent Developments
11.3 Agilent Technologies
11.3.1 Agilent Technologies Company Details
11.3.2 Agilent Technologies Business Overview
11.3.3 Agilent Technologies Gene Amplification Technologies Introduction
11.3.4 Agilent Technologies Revenue in Gene Amplification Technologies Business (2019-2024)
11.3.5 Agilent Technologies Recent Developments
11.4 Bayer Corporation
11.4.1 Bayer Corporation Company Details
11.4.2 Bayer Corporation Business Overview
11.4.3 Bayer Corporation Gene Amplification Technologies Introduction
11.4.4 Bayer Corporation Revenue in Gene Amplification Technologies Business (2019-2024)
11.4.5 Bayer Corporation Recent Developments
11.5 Rubicon Genomics
11.5.1 Rubicon Genomics Company Details
11.5.2 Rubicon Genomics Business Overview
11.5.3 Rubicon Genomics Gene Amplification Technologies Introduction
11.5.4 Rubicon Genomics Revenue in Gene Amplification Technologies Business (2019-2024)
11.5.5 Rubicon Genomics Recent Developments
11.6 BD
11.6.1 BD Company Details
11.6.2 BD Business Overview
11.6.3 BD Gene Amplification Technologies Introduction
11.6.4 BD Revenue in Gene Amplification Technologies Business (2019-2024)
11.6.5 BD Recent Developments
11.7 Roche Diagnostics
11.7.1 Roche Diagnostics Company Details
11.7.2 Roche Diagnostics Business Overview
11.7.3 Roche Diagnostics Gene Amplification Technologies Introduction
11.7.4 Roche Diagnostics Revenue in Gene Amplification Technologies Business (2019-2024)
11.7.5 Roche Diagnostics Recent Developments
11.8 BioMerieux
11.8.1 BioMerieux Company Details
11.8.2 BioMerieux Business Overview
11.8.3 BioMerieux Gene Amplification Technologies Introduction
11.8.4 BioMerieux Revenue in Gene Amplification Technologies Business (2019-2024)
11.8.5 BioMerieux Recent Developments
11.9 Bio-Rad Laboratories
11.9.1 Bio-Rad Laboratories Company Details
11.9.2 Bio-Rad Laboratories Business Overview
11.9.3 Bio-Rad Laboratories Gene Amplification Technologies Introduction
11.9.4 Bio-Rad Laboratories Revenue in Gene Amplification Technologies Business (2019-2024)
11.9.5 Bio-Rad Laboratories Recent Developments
11.10 Cepheid
11.10.1 Cepheid Company Details
11.10.2 Cepheid Business Overview
11.10.3 Cepheid Gene Amplification Technologies Introduction
11.10.4 Cepheid Revenue in Gene Amplification Technologies Business (2019-2024)
11.10.5 Cepheid Recent Developments
11.11 Life Technologies
11.11.1 Life Technologies Company Details
11.11.2 Life Technologies Business Overview
11.11.3 Life Technologies Gene Amplification Technologies Introduction
11.11.4 Life Technologies Revenue in Gene Amplification Technologies Business (2019-2024)
11.11.5 Life Technologies Recent Developments
11.12 Takara Bio
11.12.1 Takara Bio Company Details
11.12.2 Takara Bio Business Overview
11.12.3 Takara Bio Gene Amplification Technologies Introduction
11.12.4 Takara Bio Revenue in Gene Amplification Technologies Business (2019-2024)
11.12.5 Takara Bio Recent Developments
11.13 New England Biolabs
11.13.1 New England Biolabs Company Details
11.13.2 New England Biolabs Business Overview
11.13.3 New England Biolabs Gene Amplification Technologies Introduction
11.13.4 New England Biolabs Revenue in Gene Amplification Technologies Business (2019-2024)
11.13.5 New England Biolabs Recent Developments
11.14 Illumina
11.14.1 Illumina Company Details
11.14.2 Illumina Business Overview
11.14.3 Illumina Gene Amplification Technologies Introduction
11.14.4 Illumina Revenue in Gene Amplification Technologies Business (2019-2024)
11.14.5 Illumina Recent Developments
11.15 Yikang Gene
11.15.1 Yikang Gene Company Details
11.15.2 Yikang Gene Business Overview
11.15.3 Yikang Gene Gene Amplification Technologies Introduction
11.15.4 Yikang Gene Revenue in Gene Amplification Technologies Business (2019-2024)
11.15.5 Yikang Gene Recent Developments
11.16 Merck KGaA
11.16.1 Merck KGaA Company Details
11.16.2 Merck KGaA Business Overview
11.16.3 Merck KGaA Gene Amplification Technologies Introduction
11.16.4 Merck KGaA Revenue in Gene Amplification Technologies Business (2019-2024)
11.16.5 Merck KGaA Recent Developments
11.17 Promega Corporation
11.17.1 Promega Corporation Company Details
11.17.2 Promega Corporation Business Overview
11.17.3 Promega Corporation Gene Amplification Technologies Introduction
11.17.4 Promega Corporation Revenue in Gene Amplification Technologies Business (2019-2024)
11.17.5 Promega Corporation Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Abbott Laboratories
QIAGEN
Agilent Technologies
Bayer Corporation
Rubicon Genomics
BD
Roche Diagnostics
BioMerieux
Bio-Rad Laboratories
Cepheid
Life Technologies
Takara Bio
New England Biolabs
Illumina
Yikang Gene
Merck KGaA
Promega Corporation
听
听
*If Applicable.
